Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study

Table 3

Survival regression models for ESRD patient’s mortality.

	Model 1*			Final model**
	Adjusted hazard ratio	95% CI	P	Adjusted hazard ratio	95% CI	P
Type of vascular access
CVC versus AVF	2.65	1.33–5.30	0.006	3.03	1.49–6.13	0.002
C-reactive protein
Q2 versus Q1	6.01	0.79–46.7	0.083	4.91	0.62–38.6	0.130
Q3 versus Q1	8.04	1.04–62.2	0.046	8.31	1.09–63.1	0.041
Q4 versus Q1	18.1	2.51–130.0	0.004	17.3	2.40–124.9	0.005
Triglycerides
Q2 versus Q1	0.46	0.20–1.02	0.057	0.48	0.19–1.21	0.120
Q3 versus Q1	0.48	0.20–1.13	0.093	0.48	0.17–1.34	0.160
Q4 versus Q1	0.22	0.07–0.75	0.015	0.18	0.05–0.58	0.004

∗Model 1: hazard ratio adjusted for age and previous time on HD; **Final model: hazard ratio adjusted for all variable in the model. CVC: central venous catheter; AVF: arteriovenous fistula; Q: quartile; CI: confidence interval.